APA (7th ed.) Citation

Galli, E., Modoni, A., Battistini, L., Rossi, M., Guerrera, G., Pansini, I., . . . Sica, S. (2026). Neuronal injury biomarkers GFAP and neurofilament light chains (NfL) are associated with neurotoxicity and endothelial dysfunction in adult patients treated with antiCD19 CART cells. Clinical & Experimental Medicine, 26(1), 1. https://doi.org/10.1007/s10238-026-02051-4

Chicago Style (17th ed.) Citation

Galli, Eugenio, et al. "Neuronal Injury Biomarkers GFAP and Neurofilament Light Chains (NfL) Are Associated with Neurotoxicity and Endothelial Dysfunction in Adult Patients Treated with AntiCD19 CART Cells." Clinical & Experimental Medicine 26, no. 1 (2026): 1. https://doi.org/10.1007/s10238-026-02051-4.

MLA (9th ed.) Citation

Galli, Eugenio, et al. "Neuronal Injury Biomarkers GFAP and Neurofilament Light Chains (NfL) Are Associated with Neurotoxicity and Endothelial Dysfunction in Adult Patients Treated with AntiCD19 CART Cells." Clinical & Experimental Medicine, vol. 26, no. 1, 2026, p. 1, https://doi.org/10.1007/s10238-026-02051-4.